Skip Navigation


Brain Advance Access originally published online on April 21, 2009
Brain 2009 132(6):1496-1508; doi:10.1093/brain/awp087
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrowOA All Versions of this Article:
132/6/1496    most recent
awp087v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Kolodziejczyk, K.
Right arrow Articles by Attwell, D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kolodziejczyk, K.
Right arrow Articles by Attwell, D.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© 2009 The Author(s)
This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/2.0/uk/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.

The effect of N-acetyl-aspartyl-glutamate and N-acetyl-aspartate on white matter oligodendrocytes

Karolina Kolodziejczyk1, Nicola B. Hamilton1, Anna Wade1, Ragnhildur Káradóttir2 and David Attwell1

1 Department of Physiology, University College London, London, UK 2 Department of Veterinary Medicine, University of Cambridge, Cambridge, UK

Correspondence to: David Attwell, Department of Physiology, University College London, Gower Street, London, WC1E 6BT, UK E-mail: D.Attwell{at}ucl.ac.uk

Elevations of the levels of N-acetyl-aspartyl-glutamate (NAAG) and N-acetyl-aspartate (NAA) are associated with myelin loss in the leucodystrophies Canavan's disease and Pelizaeus-Merzbacher-like disease. NAAG and NAA can activate and antagonize neuronal N-methyl-D-aspartate (NMDA) receptors, and also act on group II metabotropic glutamate receptors. Oligodendrocytes and their precursors have recently been shown to express NMDA receptors, and activation of these receptors in ischaemia leads to the death of oligodendrocyte precursors and the loss of myelin. This raises the possibility that the failure to develop myelin, or demyelination, occurring in the leucodystrophies could reflect an action of NAAG or NAA on oligodendrocyte NMDA receptors. However, since the putative subunit composition of NMDA receptors on oligodendrocytes differs from that of neuronal NMDA receptors, the effects of NAAG and NAA on them are unknown. We show that NAAG, but not NAA, evokes an inward membrane current in cerebellar white matter oligodendrocytes, which is reduced by NMDA receptor block (but not by block of metabotropic glutamate receptors). The size of the current evoked by NAAG, relative to that evoked by NMDA, was much smaller in oligodendrocytes than in neurons, and NAAG induced a rise in [Ca2+]i in neurons but not in oligodendrocytes. These differences in the effect of NAAG on oligodendrocytes and neurons may reflect the aforementioned difference in receptor subunit composition. In addition, as a major part of the response in oligodendrocytes was blocked by tetrodotoxin (TTX), much of the NAAG-evoked current in oligodendrocytes is a secondary consequence of activating neuronal NMDA receptors. Six hours exposure to 1 mM NAAG did not lead to the death of cells in the white matter. We conclude that an action of NAAG on oligodendrocyte NMDA receptors is unlikely to be a major contributor to white matter damage in the leucodystrophies.

Key Words: leucodystrophy; Pelizaeus-Merzbacher-like disease; Canavan's disease; glutamate; NMDA

Abbreviations: mGluR3, metabotropic glutamate receptor 3; NAA, N-acetyl-aspartate; NAAG, N-acetyl-aspartyl-glutamate; NMDA, N-methyl-D-aspartate; TTX, tetrodotoxin

Received October 8, 2008. Revised February 11, 2009. Accepted March 2, 2009.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
NeurologyHome page
F. Mochel, U.F.H. Engelke, J. Barritault, B. Yang, N. H. McNeill, J. N. Thompson, A. Vanderver, N. I. Wolf, M. A. Willemsen, F. W. Verheijen, et al.
Elevated CSF N-acetylaspartylglutamate in patients with free sialic acid storage diseases
Neurology, January 26, 2010; 74(4): 302 - 305.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.